Position- and base pair-specific comparison of p53 mutation spectra in human tumors: elucidation of relationships between organs for cancer etiology. by Lutz, W K et al.
Position- and Base Pair-specific Comparison of p53 Mutation Spectra in
Human Tumors: Elucidation of Relationships between Organs for Cancer
Etiology
Werner K. Lutz, Tamas Fekete, andSpiros Vamvakas
Department of Toxicology, University of Wurzburg, WQrzburg, Germany
A new approach to analyze the p53 mutation database of the European Molecular Biology
Laboratory for a comparison of mutation spectra is described, with the aim of investigating
organ specificityofetiological factors andputativeorgan-to-organ relationships in cancerpatho-
genesis. The number ofentries ofeach nudeotide- andbase-pair substitution-specific mutation
was divided bythe total number oftumors analyzed. For each organ pair, the difference ofthe
ftequencies was calculated (absolute values) and, going through all mutations, the sum ofthe
mutation-specific frequencydifferences was cakulated. Resulting values could range from 0 (fill
concordance) to 2 (fill discordance). Skin, lung, andurnarybladdershowedhighlyindependent
mutation spectra (maximum discordance value = 1.48 for sin versus brain), in agreement with
thepresence ofspecificfactors responsiblefora largenumberoftherespectivetumors (VVlight,
smoking, aromatic amines). The three organs with the smallest sum ofdiscrdancevalues were
mammary gland (breast), colon, and esophagus. The minimum organ-to-organ discordance
value was 0.95, for stomach versus colon. Forthese organs, common, possiblyalso endogenous,
cancer risk factors could bepostulated as contributing to the observed mutation spectum. The
remainingcancers (ovary, sarcoma, leukemia/lymphoma, brain, head and neck, and stomach, in
orderofincreasingdiscordance) were ofintermediate rangeandshowedamixofvalues. Reasons
fordose relationship to some oftheotherorgans and marked diffirences to others arediscussed.
Exdusion ofthe "hot-spot" mutations didnotmarkedliyalterthe observedrdationships, indicat-
ing that a putative selective growth advantage does not cover up the etiological basis for the
observed mutation spectrum. It isepected that much more insight into carcinogenesis and can-
cer could be gained by firther exploratory analyses ofmutation databases. Key words cancer,
cancer risk factor, mutation spectm, organ specificity, p53, tumor etiology, tumor-suppressor
gene. EnvironHealthPrect106:207-211 (1998). [Online 10 March 1998]
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The p53 tumor-suppressor gene is mutated
in approximately 50% of human cancers,
and the spectra of substitution mutations
have been analyzed to elucidate tumor
pathogenesis (1,2). The major issue has been
the identification and discussion ofthe most
frequently mutated codon sites ("hot spots")
and the analysis ofthe prevalence ofthe var-
ious types ofbase-pair substitutions.
A database ofall published p53 substitu-
tion mutations in human tumors and cell
lines is available on-line through the
European Bioinformatics Institute or through
the International Agency for Research on
Cancer (3). More than 5,000 mutations had
been collected by 1996. The database repre-
sents a unique source ofinformation that can
be analyzed in many different ways. A recent
example concerning the organ specificity has
been published by Lasky and Silbergeld in
EHP(4).
Base-pair substitutions are the result of
mispairingduring DNAreplication. This mis-
pairing can be due to primary DNA lesions,
such as DNAadducts, or to spontaneous repli-
cation errors. DNA adducts are formed both
by exogenous carcinogens (5) and endoge-
nous agents (6). Theadductprofile is notonly
carcinogen and basespecific but appears to be
position specificalso. For instance, site-target-
ed formation of carcinogen-DNA adducts
contributes to the p53 mutation spectrum
seen in lung cancer (2'). Therefore, if muta-
tion spectra can be analyzed not only for the
frequency ofspecific types ofbase-pair substi-
tution but also in terms of position, this
might improve the analysis of relationships
between organswith respect to theetiologyof
the respectivetumors.
Methods
Database andselection ofenties. The data-
base was accessed on 17 January 1997 at
http.//www.eb.ac.uk, and 5,174 entries were
retrieved. They were converted to a
Microsoft Excel file, which formed the basis
of all selection procedures and calculations
described. Lines that contained the following
names of organs or cancers in column G,
"tumor type," were used (number of recov-
ered entries in parentheses): urinary bladder
(178), brain (207), breast (331), colon (461),
esophagus (146), head and neck (244),
leukemia/lymphoma (349), lung (453),
ovary (218), sarcoma (110), skin (125), and
stomach (194). Misspelled entries were not
considered. The database was ordered by the
nucleotide position (145 to 1024; i.e., from
the first nucleotide of codon 49 to the first
nucleotide of codon 342) and, for each
nudeotide, by the specific base change noted
in column E (for instance, 469 G toA, 469 G
to C, 469 G toT).
Analysis ofthe relationship between two
organs. For each of the 12 organs (= 12
columns), we divided the number of entries
for each mutation by the total number of
tumors analyzed. These frequencies indicated
the relative abundance ofa specific mutation.
For all organ pairs, we calculated the
(absolute) difference of the relative frequen-
cies, and, going through all mutations, calcu-
lated the sum of the differences. The proce-
dure is illustrated in Table 1 for nucleotide
469 (i.e., for the first base ofcodon 157). For
the comparison between colon and esopha-
gus, the G toT transversion ofnudeotide469
has practically the same frequency in the two
organs, and thedifference is minimal (10.0065
- 0.00681 = 0.0003). On the other hand, the
same mutation displays a fivefold higher rela-
tive frequency in lung tumors as compared to
colon tumors (10.0375 - 0.00651 = 0.0310).
Large differences in many positions and sub-
stitutions result in large discordance values
when the sum ofthe differences is calculated.
In the case offull concordance ofthe muta-
tional spectrum between two organs, the sum
of the differences is 0. For complete discor-
dance, a value of2 will result: ifa relative fre-
quency >0 in one organ is always opposite a
relative frequency of0 in the other organ, the
sum ofthedifferenceswill be (1+1 =) 2.
Organs considered. A preliminary analysis
which included the entries for cervix (cer; 31
entries), pancreas (pan; 94), prostate (pro; 46),
renal (kid; 36), thyroid (thy; 32), and uterus
(ute; 36) revealed that organs with only a
small numberofentries showedlarger sumsof
discordance values than organs with a large
number of analyzed tumors (Fig. 1). This
might be due to the fact that with a small
sample, the minimum relative frequency is
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larger than with a large sample. We limited
the analysis to those organs for which at least
100 mutations had been recorded. In this
group, onlythe skin could have been affected
by the artifact. However, another explanation
for the large discordance value ofskin is put
forward below; its inclusion in the analysis
was considered appropriate.
Results
The organ-to-organ relationship for the
mutation spectra in the p53 gene was ana-
lyzed by calculating the relative frequencies
ofposition- and base pair-specific substitu-
tion mutations for each organ, and then
summing up organ-to-organ differences of
the frequencies over all mutations. The
results are shown in Table 2 in the form ofa
12 x 12 matrix containing a set of12 x 11 =
132 organ-to-organ values in duplicate.
Small values indicate small differences
between the mutation spectra (i.e., concor-
dance); largevalues indicate largerdifferences
(i.e., discordance). The theoretical span of
values is from 0 (full concordance) to 2
(complete discordance). Observed values
ranged from a minimum of 0.95 (colon
compared with stomach) to a maximum of
1.48 (skin compared with brain). The fre-
quency distribution ofthe values is shown in
Figure 2. It is defined by a mean and stan-
dard deviation of1.23 ± 0.14. The median is
1.26, the mode is 1.30, the lower quartile
(25th percentile) is at 1.10, and the upper
quartile (75th percentile) is at 1.36. The dis-
tribution therefore is quitesymmetrical.
For the following discussion, the values
shown in Table 2 have been grouped. The
first and fourth quartiles of the values are
marked; the two intermediate quartiles are
not marked specifically. A number ofobser-
vations can be made on this basis. The three
organs that exhibit the largest sum ofdiscor-
dance values are the skin, lung, and urinary
bladder, and the three organs with the
smallest sum of values are the mammary
gland, colon, and esophagus. The remaining
organs/cancers (sarcoma, stomach, head and
Table 1. Procedure forthe analysis ofthe organ-to-organ relationships for p53mutation spectra in tumors,
exemplified forthefirstnucleotide ofcodon 157, nucleotide 469(G)
Base change
G->A G-C G-T
No. oftumors with mutation
Esophagus (146tumors analyzed) 1 0 1
Colon (461 tumors analyzed) 0 2 3
Lung (453tumors analyzed) 0 0 17
Frequencies oftumors with mutation
Esophagus 0.0068(1/146) 0 0.0068
Colon 0 0.0043 0.0065
Lung 0 0 0.0375
Organ-to-organ difference offrequencies (absolute values)
Esophagusto colon 0.0068 0.0043 0.0003
Sum fornucleotide 469 0.0114
Sum for all nucleotides 1.03a
Colon-to-lung 0 0.0043 0.0310
Sumfor nucleotide 469 0.0353
Sum for all nucleotides 1.37a
8Value forTable 2.
neck, brain, leukemia/lymphoma, ovary, in
the orderofdecreasingdiscordance) range in
between and show a mix ofvalues, with
close relationship to some of the other
organs and marked differences to others.
The first group can be characterized by
well-known, specific high-risk factors: sun-
light for skin, cigarette smoking for lung,
and aromatic amines for the urinary bladder.
Those at the other end ofthe ranking are in
part hormone dependent (mammary, ovary)
or have multiple risk factors (esophagus,
colon). Most ofthese also appear to have an
endogenous component (8). This analysis
therefore could provide some insight into
the question ofthe relative contributions of
different factors to carcinogenesis.
Specific Etiology
Values in the fourth quartile were obtained
most frequently for skin tumors (against all
other organs). Exposure to sunlight is the
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Figure 1. Sum of organ-to-organ discordance val-
ues for 18 organs, as a function of the number of
tumors analyzed. Abbreviations: ubl, urinary blad-
der; bra, brain; mam, mammary gland (breast); col,
colon; eso, esophagus; h&n, head and neck; I&l,
leukemia and lymphoma; lun, lung; ova, ovary; sar,
sarcoma; ski, skin; sto, stomach; kid, renal; thy,
thyroid; pro, prostate; ute, uterus; cer, cervix; pan,
pancreas.
Table 2. Discordance values forthe relationships between organs with respectto the p53mutation spectra in human tumors (the procedure forthe calculation of
the values is exemplified in Table 1)
ubl bra mam col eso h&n l&l lun ova sar ski sto
ubl 0 1.33 1.18 1.30 1.25 1.31 1.28 1.32 1.33 1.30 1.44a 1.41 a
bra 1.33 0 1.12 1.00b 1.18 1.26 1.09b 1.39a 1.06b 1.12 1.48a 1.09b
mam 1.18 1.12 0 1.06b 1.06b 1.03b 1.05b 1.13 1.00b 1.18 1.40a 1.19
col 1.30 1.00b 1.06b 0 1.03b 1.26 1.01b 1.37a 1.07b 1.26 1.40a 0.95b
eso 1.25 1.18 1.06b 1.03b 0 1.04b 1.10b 1.19 1.11 1.20 1.41a 1.19
h&n 1.31 1.26 1.03b 1.26 1.04b 0 1.16 1.15 1.20 1.24 1.37a 1.30
1&l 1.28 1.1gb 1.05b 1.01b 1.10b 1.16 0 1.31 1.12 1.28 1.45a 1.23
lun 1.32 1.39a 1.13 1.37a 1.19 1.15 1.31 0 1.21 1.37a 1.428 1.43a
ova 1.33 1.06b 1.00b 1.07b 1.11 1.20 1.12 1.21 0 1.24 1.46a 1.08b
sar 1.30 1.12 1.18 1.26 1.20 1.24 1.28 1.37a 1.24 0 1.43a 1.30
ski 1.44a 1.48a 1.40a 1.40a 1.41 a 1.37a 1.45a 1.42a 1.46a 1.43a 0 1.39a
sto 1.41a 1.09b 1.19 0.95b 1.19 1.30 1.23 1.43a 1.08b 1.30 1.39a 0
Sum 14.44a 13.11 12.39b 12.71b 12.77b 13.31 13.09 14.288 12.87 13.92 15.66a 13.56
Abbreviations: ubl, urinary bladder; bra, brain; mam, mammary gland (breast); col, colon; eso, esophagus; h&n, head and neck; l&l, leukemia and lymphoma; lun, lung; ova, ovary; sar,
sarcoma; ski, skin; sto, stomach.
'Ialues belonging tothe fourth quartile (>75th percentile).
bValues belonging tothe first quartile {<25th percentile).
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most important exogenous risk factor for
skin tumor induction. This factor does not
operate in the other tissues examined here.
Thus, the present analysis allowed the iden-
tification of an organ where tumor forma-
tion is based primarily on risk factors that
do not act in other organs. It also indicates
that mutation spectra in the tumor retain
etiological information, although the pheno-
typic selection of mutations is expected to
bring about a modification of the carcino-
gen-derived spectrum in the normal tissue.
The fact that the mutation spectra of skin
tumors are clearly different from all other
investigated human cancers but similar to
those observed in UV-light model systems
was also demonstrated in a recent compari-
son ofp53 mutations in skin cancers with
those in all kinds ofinternal cancers (9,10).
The lung exhibited the second mostlarge
organ-to-organ discordance values. Tobacco
smoking is the prominent organ-specific risk
factor. However, smoking is also involved in
the formation of other tumors, such as
tumors ofthe head and neck and the esopha-
gus. Whywere these organs not closely relat-
ed to the lung in the present analysis? One
explanation might lie in the fact that it is not
smoking alone, but the combination of
smoking and excessive alcohol drinking
which is responsible for some 75% of
esophageal and 90% ofhead and neck can-
cers, whereas alcohol does not appear to be a
risk factor in lung cancer (11,12).
Furthermore, the result ofthe present analy-
sis could support the idea that the smoke-
related carcinogens which dominate the
process in the lung are different from those
operating inpharynx, larynx, andesophagus.
Tumors of the urinary bladder also
appeared to have little in commonwith other
organs, including the lung (organ-to-organ
value 1.32), although cigarette smoking is
also ariskfactor forbladder cancer. However,
the association with smoking is much
stronger forlung cancer than for bladder can-
cer. Therelative riskforsmokers comparedto
nonsmokers to develop lung cancer is 11.3,
whereas for bladder cancer the relative risk is
only 2.2 (13,14). Second, as previously sug-
gested by DNA adduct studies, aromatic
amines areamajorriskfactorforbladdercan-
cer (15), whereas carcinogenicity ofcigarette
smokingfor the lung appears to be based pri-
marily on other carcinogens, such as polynu-
clear aromatic hydrocarbons and nitroso
compounds, and is strongly modulated by
tumor-promoting aspects ofsmoking-associ-
ated toxicity (16). Hence, the dissimilarity in
p53 mutation spectra between the lung and
the urinary bladder reflects both qualitative
and quantitative differences in the role ofcig-
arette smoke carcinogens for the two organs.
This distinctp53mutation spectrum in blad-
der tumors was also reported in a previous
comparison with the mutation spectra of
smoking-related lung tumors and smoking-
independentcoloncancer (17).
Sarcomas also exhibited relatively little
concordance with other cancers. The dosest
was with brain tumors with a value of 1.12.
We cannot offer a sound hypothesis for any
specific etiology ofhuman sarcoma forma-
tion as indicated by the present analysis,
especially in view of the fact that sarcomas
arise in all kinds oftissues and exhibit differ-
ent differentiation grades. The artifact of
apparently large discordance values associat-
ed with low numbers of analyzed tumors
may apply here. Sarcoma was the tumor
class with the lowest numberofentries (110)
considered in this analysis. When more data
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Figure 2. Frequency distribution ofthe organ-to-organ discordance values shown in Table 2.
become available, this artifact should disap-
pear, and it might be possible to stratify the
entries by type and location to see whether
relationships are hidden by the diversity of
the tumors registered as sarcomas.
Related Organs
The small values in Table 2 indicate a rela-
tionship between the two organs consid-
ered, based on similar tumor etiology or
related tumor biology. The lowest value
was obtained for the pair colon and stom-
ach. Numerous risk factors are discussed
for the two sites. A high-fat/low-fiber diet
appears to promote colon carcinogenesis,
whereas gastritis, predominantly in connec-
tion with infection, is associated with
tumorigenesis in the stomach. In both
cases, exogenous DNA-reactive carcinogens
cannot fully explain the process ofcarcino-
genesis, and background DNA damage,
together with tumor-promoting aspects
such as the stimulation of cell division,
might be more important in both tissues.
Background DNA damage could be postu-
lated, for instance, from oxidative stress
and lipid peroxidation resulting in the
increased formation ofoxygen radicals and
secondary products such as aldehydes. Such
a common background mechanism may
explain the close relationship between these
two organs in terms ofmutation spectra.
The colon showed the largest number
ofclose relationships with, for example, the
hormone-dependent tissues ofthe mamma-
ry gland and the ovary, as well as with
brain and leukemia/lymphoma. More
refined analyses will be required to investi-
gate which of these relations are based on
similar pathogenesis.
Tumors of the head and neck and the
esophagus were also closely interrelated.
This is in line with regular alcohol con-
sumption, particularlywhen combined with
cigarette smoking. Genotoxic aldehydes,
both present directly in cigarette smoke as
well as in intermediate metabolites ofalco-
hol, could form the common link. Because
aldehydes are also important secondary
products oflipid peroxidation, this class of
carcinogens could also account at least in
part for other relationships, for which no
sound explanation can be given at this time.
Leukemias/lymphomas displayed similar-
ities with cancers of brain and colon, and
large discordance to cancers having known
exogenous risk factors, such as skin, lung,
and bladder. C-G to T-A transitions at CpG
sites, possibly as a result ofoxidative deami-
nation of5-methylcytosine, were particularly
frequent in tumors ofthe brain, colon, stom-
ach, and endometrium and in hematological
cancers (1). Hence, although specific chemi-
cals and viruses may be contributing factors,
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the present analysis would support the
hypothesis of a strong endogenous compo-
nent in the etiology ofleukemias and lym-
phomas.
The mutation pattern oftumors of the
mammary gland (breast cancer) was clearly
distinct only from the one in skin tumors
(1.40) but revealed relationships above
average with all other organs (<1.19) and
even showed a value of 1.13 with the lung.
The closest relationship was observed with
the ovary, another hormone-dependent
organ. Although exogenous factors con-
tribute at least to a certain extent to the
breast cancer risk, established factors can-
not account for the majority ofbreast can-
cers. The association with high intake of
animal fat is increasingly contested, and
exposure to polycyclic aromatic hydrocar-
bons (PAHs) known to cause mammary
gland cancer in animals has not been
strongly associated with breast cancer in
humans (18,19). The present analysis
would support the multifactorial etiology
without prominent specific factors.
Discussion
The database on p53 mutations in human
tumors provides a unique opportunity to
investigate the molecular epidemiology of
cancer. In this paper, the question of
whether the mutation spectra in different
organs can be analyzed to reveal etiological
similarities and differences was addressed.
The analysis identified organs with lit-
tle relationship to others, reflecting a rather
independent pathogenetic mechanism
based on specific exogenous factors (skin,
lung, bladder). On the other hand, the hor-
mone-dependent tissues of the breast and
ovary, gastrointestinal tumors, as well as
leukemia/lymphoma and brain tumors
showed substantial overlap. The hypothesis
of a common pathway in the pathogenesis
of these tumors, for instance by back-
ground DNA damage, could be formulat-
ed. This is supported by a descriptive epi-
demiological analysis that revealed relative-
ly small differences between incidence rates
reported worldwide for some of these can-
cers (8). However, it cannot be excluded
that two organ-cancers have quite diverse
etiology and still have a similar mutation
spectrum. More information on the speci-
ficity ofmutational fingerprints ofdifferent
carcinogens will be required to shed more
light on this question.
The mutation spectrum in a tumor is
the result oftwo main factors: the nature of
the DNA damage and the ability of the
mutations formed to convey an advantage
to the cell in terms ofclonal expansion and
tumor progression. The latter property
results in so-called hot spots. The question
therefore is whether hot spots should be
included in the present analysis ofetiologic
factors or whether they distort the situation
and are better omitted.
In a recent analysis, hot spots were shown
not to be universal for all organs, and the dis-
tribution ofbase-pair changes over hot spots
also varied by cancer (4). Based on our analy-
sis, for instance, the share among all muta-
tions ofthe hot spot mutation CGT to TGT
in codon 273 ranged from 0.4% in head and
neck tumors to 10.6% in the brain. The
CGT to CAT mutation in codon 273 con-
tributed between 1.6% in lung and 6.7% in
the mammary gland. Therefore, hot spots do
retain some organ-specific features and could
be included in the present type ofanalysis. In
fact, when we restricted our analysis to those
mutations that contributed less than 3% of
all documented mutations, no additional
information could be derived in terms ofeti-
ological specificity (data not shown). The
inclusion of the hot-spot mutations in the
present analysis therefore did not interfere
with our interpretation. However, this is not
a general rule and does not exclude the possi-
bility that certain other questions maybe bet-
ter addressed by a separate analysis of hot-
spot and non-hot-spot-mutations.
Recent epidemiological studies with cig-
arette smokers indicated a markedly steeper
rise of the incidence of adenocarcinoma
compared with squamous cell carcinoma of
the lung (20-22). In the past, the associa-
tion between adenocarcinoma and cigarette
smoking was considered to be weak or even
questionable, mainly based on the fact that
adenocarcinoma is the most frequent type
among nonsmokers. The percentage ofciga-
rettes with filter tips increased from 0.56%
in 1950 to over 90% in the 1980s. The
nicotine concentration from filter-tip ciga-
rettes is severalfold lower. Hence, the smok-
er offilter-tip cigarettes tends to inhale more
deeply and smoke more intensely, so that
the smaller bronchi and bronchio-alveolar
regions, the site of origin of adenocarcino-
mas, are exposed to higher amounts oflung-
specific smoke carcinogens (15). Due to the
long latency period oflung cancer develop-
ment, a small proportion of lung cancers
investigated today is due to smoking of
unfiltered cigarettes in the past decades,
when adenocarcinoma may not have been
related very strongly to tobacco smoke. The
results of the present analysis are in agree-
ment with the epidemiological evidence that
in recent years smoke-induced lung tumor
formation is not confined to one cell type.
In the past, much information has been
collected on the relative abundance ofspecific
types ofbase pair substitutions in tumors of
various organs. For instance, the strong inde-
pendence of the mutation spectrum of skin
tumors is a result of the unusual abundance
ofC to T transitions, considered to be a con-
sequence of UV light-induced dimer forma-
tion at tandem pyrimidine sites. In colon
tumors, 63% of the base pair changes were
reported to be G to A transitions; the G to T
transversion contributed only 9% (1). In the
lung, the ratio was 24%:40%, consistent with
DNA adducts from bulky carcinogens such
as PAHs, which have been shown to lead pre-
dominantly to G to T transversions. In breast
tumors, the ratio was 36%:13% (i.e., some-
where in between, indicative ofthe multifac-
torial process of carcinogenesis in the mam-
mary gland). Such data, together with the
knowledge ofthe relationship between specif-
ic adducts and their mutation spectra, should
now be combined with the position-specific
information derived from the present analysis
in order to take filll advantage ofthe possibil-
ities of the molecular epidemiologic
approach.
The focus of the present analysis was
the base pair-specific, quantitative, organ-
to-organ comparison of the complete p53
mutation spectra. It allowed a number of
interesting hypotheses to be formulated.
Numerous aspects may have been over-
looked, and others may only be discovered
with a more refined analysis, especially by
stratifying the data by histological type and
information on specific exposures. This
will be possible as the database increases in
size and adopts a more consistent terminol-
ogy for the entries.
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